Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specified Drug Use-results Survey of Betanis Tablets in OAB Patients With Coexisting Glaucoma

NCT01898624 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01898624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01898624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specified Drug Use-results Survey of Betanis Tablets in OAB Patients With Coexisting Glaucoma
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
December 4, 2012
Completion date
January 10, 2018
Enrollment
300 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder